GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinocelltech Group Ltd (SHSE:688520) » Definitions » Beneish M-Score

Sinocelltech Group (SHSE:688520) Beneish M-Score : -1.54 (As of Jun. 27, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Sinocelltech Group Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -1.54 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Sinocelltech Group's Beneish M-Score or its related term are showing as below:

SHSE:688520' s Beneish M-Score Range Over the Past 10 Years
Min: -2.45   Med: 0.19   Max: 2772.16
Current: -1.54

During the past 9 years, the highest Beneish M-Score of Sinocelltech Group was 2772.16. The lowest was -2.45. And the median was 0.19.


Sinocelltech Group Beneish M-Score Historical Data

The historical data trend for Sinocelltech Group's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinocelltech Group Beneish M-Score Chart

Sinocelltech Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only 1.91 361.26 2.94 -1.97 -2.06

Sinocelltech Group Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.95 -1.92 -2.45 -2.06 -1.54

Competitive Comparison of Sinocelltech Group's Beneish M-Score

For the Biotechnology subindustry, Sinocelltech Group's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinocelltech Group's Beneish M-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sinocelltech Group's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Sinocelltech Group's Beneish M-Score falls into.


;
;

Sinocelltech Group Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Sinocelltech Group for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.6313+0.528 * 1.016+0.404 * 0.8485+0.892 * 1.1146+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.5723+4.679 * 0.074771-0.327 * 0.8241
=-1.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar25) TTM:Last Year (Mar24) TTM:
Total Receivables was ¥881 Mil.
Revenue was 519.737 + 575.727 + 632.312 + 692.166 = ¥2,420 Mil.
Gross Profit was 493.105 + 545.026 + 604.867 + 668.096 = ¥2,311 Mil.
Total Current Assets was ¥1,611 Mil.
Total Assets was ¥3,450 Mil.
Property, Plant and Equipment(Net PPE) was ¥1,531 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥540 Mil.
Total Current Liabilities was ¥2,194 Mil.
Long-Term Debt & Capital Lease Obligation was ¥972 Mil.
Net Income was 63.768 + -38.003 + 24.248 + 51.508 = ¥102 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ¥0 Mil.
Cash Flow from Operations was -106.918 + -64.567 + 58.425 + -43.349 = ¥-156 Mil.
Total Receivables was ¥484 Mil.
Revenue was 612.503 + 508.098 + 571.176 + 479.296 = ¥2,171 Mil.
Gross Profit was 592.017 + 493.847 + 556.535 + 464.097 = ¥2,106 Mil.
Total Current Assets was ¥1,125 Mil.
Total Assets was ¥2,828 Mil.
Property, Plant and Equipment(Net PPE) was ¥1,406 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥308 Mil.
Total Current Liabilities was ¥1,958 Mil.
Long-Term Debt & Capital Lease Obligation was ¥1,191 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(880.594 / 2419.942) / (484.285 / 2171.073)
=0.363891 / 0.223063
=1.6313

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(2106.496 / 2171.073) / (2311.094 / 2419.942)
=0.970256 / 0.95502
=1.016

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1611.064 + 1530.977) / 3449.606) / (1 - (1124.763 + 1405.881) / 2827.78)
=0.089159 / 0.105077
=0.8485

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=2419.942 / 2171.073
=1.1146

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 1405.881)) / (0 / (0 + 1530.977))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(540.055 / 2419.942) / (308.156 / 2171.073)
=0.223169 / 0.141937
=1.5723

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((971.904 + 2193.911) / 3449.606) / ((1190.597 + 1958.325) / 2827.78)
=0.917732 / 1.113567
=0.8241

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(101.521 - 0 - -156.409) / 3449.606
=0.074771

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Sinocelltech Group has a M-score of -1.54 signals that the company is likely to be a manipulator.


Sinocelltech Group Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Sinocelltech Group's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinocelltech Group Business Description

Traded in Other Exchanges
N/A
Address
Kechuang Seventh Street, Beijing Economic and Technological Development Zone, Room 307, Building 5, Courtyard 31, Beijing, CHN, 100176
Sinocelltech Group Ltd is engaged in development and industrialization of biopharmaceutical products such as monoclonal antibodies, recombinant proteins and vaccines. The company has developed technology platforms in protein expression vectors, cell line development, serum-free medium development, stoichiometrically controlled fed-batch cell culture, process scale-up, and protein purification. Its capacities include stable CHO cell line development, cell banking and certification, serum-free and protein-free culture medium development, fed-batch cell culture process development, optimization, and process scale-up; protein purification development, and large scale production.
Executives
Xie Liang Zhi Director

Sinocelltech Group Headlines

No Headlines